Tata group company makes Corona test kit, report will be found in an hour
This kit developed by India Health Fund, a unit of Tata Trust, is being claimed to receive test reports within an hour.
8th April, 2020
Molbyo Diagnostics Pvt Ltd, backed by the India Health Fund, a unit of the Tata Trust, has designed the Corona Test Kit. The TruNet Beta COV Test Kit is the second facility built in India, which has been allowed to be certified by ICMR in a very short period of time. This information is given through a press release issued by Tata Steel.
The kit has recently received approval from the Indian Council of Medical Research (ICMR) through the Center for Health Research and Innovations (CHRI) for testing the TRUNAT beta COV test, a test kit used by patients for screening Kovid-19. This kit will be used as a screening test for Kovid-19 and test reports can be received within hours. From this, investigation reports can be received in a single day and if needed, the process of keeping the patient away from other people can be started. This will reduce the risk of infection until you wait for the investigation report. This kit will cost 1350 rupees or less in testing.
Support for MolBio diagnostics and the approval of the TruNat Beta COV test are considered important in the India Health Fund's fight against infectious diseases. Dr. Chandrasekhar Nair, Chief Technical Officer of MolBio Diagnostics Pvt Ltd, said that it is most important today to rapidly increase the availability of molecular diagnostics and have the necessary financial support. This can help in getting ready to keep global epidemics like Kovid-19 under control.
India Health Fund's Chief Executive Officer Madhav Joshi has said that India Health Fund's initiative Quest for Innovations 2020 is for all entrepreneurs, innovators and scientists to come forward with their imaginations and solutions and accelerate the development and use of their tools and technology Is an opportunity to collaborate with India Health Fund.
Khushbu Kumari Jha